Biogen Skids On ‘Low-Quality’ Beat, Cuts Profit Guidance Following Reata Buyout
Investor's Business DailyBiogen stock skidded Wednesday on a “low-quality” sales beat that relied on other revenue. But analysts noted Skyclarys’ strong launch.
The post Biogen Skids On 'Low-Quality' Beat, Cuts Profit Guidance Following Reata Buyout appeared first on…